Article Listing - Eisai realigns US operations, with 20% job cuts

INDIA; DRUG REVIEW DELAYS POLICY

3 February 1992

A new review of the drug products which are to remain under government price control is reportedly causing delay in...

MOZAMBIQUE HEALTH CARE

3 February 1992

A bill allowing the establishment of a private health care sector in Mozambique for the first time since 1975 is...

HOECHST ATTACKED OVER MIFEPRISTONE

3 February 1992

Hoechst Celanese Corp, a US subsidiary of Hoechst-AG, one of the companies behind the manufacturers of the controversial abortifacient drug...

ADVANCE IN DIABETES RESEARCH

3 February 1992

Diabetes researchers at the University of Texas Southwestern Medical Center, Dallas, USA, have taken a first step towards the creation...

VESTAR'S AMBISOME LAUNCHED IN THE UK

3 February 1992

The first liposomal formulation of a drug has now been launched in the UK, in the form of Vestar's Ambisome,...

ENZON AND ALLELIX IN EGF DEAL

3 February 1992

Enzon has signed an agreement with Allelix Biopharmaceuticals for the development of a modified version of epidermal growth factor, using...

GOOD 1991 RESULTS FOR MERCK AND FOREST LABS

3 February 1992

Fourth quarter and 1991 year-end financial results announced in the USA over the past week were led by the generics...

US APPROVAL FOR SB'S TRIOSTAT

3 February 1992

- SmithKline Beecham has received approval from the US Food and Drug Administration to market Triostat (tri-iodothyronine) its orphan drug...

FOREST LAB'S ROBIN BURROWS RETIRES

3 February 1992

- Robin Burrows has resigned as vice president of corporate development with Forest Labor-atories Inc, and is presently acting as...

NEW DIRECTOR AT INSALUD

3 February 1992

- Antolin Rodriguez Martinez has been appointed as director of Spain's national institute for health, Insalud.

Showing 94841-94850 of 95325 articles

Go to beginningPreviousNextGo to end